Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity

Citation
F. Pons et al., Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity, NUCL MED C, 20(6), 1999, pp. 525-528
Citations number
15
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging
Journal title
NUCLEAR MEDICINE COMMUNICATIONS
ISSN journal
01433636 → ACNP
Volume
20
Issue
6
Year of publication
1999
Pages
525 - 528
Database
ISI
SICI code
0143-3636(199906)20:6<525:QEOBSI>2.0.ZU;2-Z
Abstract
Interest in the assessment of activity of Paget's disease has increased sin ce the advent of effective therapies. The aim of this study was to develop a quantitative method for the scintigraphic assessment of Pager's disease a ctivity in bone. Twenty patients with Paget's disease were studied prospect ively. A scintigraphic visual activity index, together with a quantitative activity index that reflects both the extent and activity of the disease, w as obtained for each patient. The quantitative activity index is calculated as the sum of the activity (geometric mean measured from the anterior and posterior views) for all affected bones divided by a reference obtained in non-affected bone. To evaluate the validity of the scintigraphic methods, s everal biochemical markers of bone turnover were assessed: serum total alka line phosphatase and serum propeptide aminoterminal of type I procollagen ( PINP) as markers of bone formation; urinary hydroxyproline and urinary N-te rminal cross-linked telopeptide of type I collagen (NTx) as markers of bone resorption. The visual and quantitative scintigraphic indices were highly correlated (r = 0.78, P < 0.0001). The highest correlations between the bio chemical markers and the quantitative activity index were found for PINP (r = 0.69, P < 0.001), which was the most sensitive marker of bone formation, and for urinary NTx (r = 0.63, P < 0.005), which was the most sensitive ma rker of bone resorption. In conclusion, quantitative evaluation of bone sci ntigraphy allows easy and objective assessment of Pager's disease activity and it may be useful in evaluating the effectiveness of therapies. ((C) 199 9 Lippincott Williams & Wilkins).